Skip to content
- December 17, 2020
Rheos Medicines and PatientsLikeMe Announce Strategic Collaboration to Investigate Underlying Metabolic Drivers of Immune-Mediated Disease
- October 21, 2020
Rheos Medicines Appoints Dania Rabah, Ph.D., as Chief Scientific Officer
- September 28, 2020
Rheos Medicines to Participate in Stifel 2020 Immunology and Inflammation Virtual Summit
- February 18, 2020
Rheos Medicines to Present at the Cowen and Company 40th Annual Health Care Conference
- December 19, 2019
Rheos Medicines Announces Worldwide Collaboration with Roche to Discover and Develop Novel Medicines in the Field of Immunometabolism
- December 12, 2019
Rheos Medicines Announces Publication of Perspective in Cell Metabolism Highlighting the Rationale and Potential of Employing Principles of Immunometabolism to Discover and Develop Novel Medicines
- October 21, 2019
Rheos Medicines Appoints Barbara S. Fox as Chief Executive Officer
- March 07, 2019
Rheos Medicines to Present at the Cowen and Company 39th Annual Health Care Conference
- October 10, 2018
Rheos Medicines Expands Leadership Team with Appointments of Gad Soffer as Chief Operating Officer and J. Duncan Higgons to Board of Directors
- March 22, 2018
Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases